• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

Introduction to 4-(Chloromethoxy)-3-iodo-5-nitrobenzonitrile (CAS No. 1504881-35-9)

4-(Chloromethoxy)-3-iodo-5-nitrobenzonitrile, identified by its Chemical Abstracts Service (CAS) number 1504881-35-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of benzonitrile derivatives, characterized by its nitro, chloromethoxy, and iodo substituents, which contribute to its unique chemical properties and reactivity. The strategic placement of these functional groups makes it a valuable intermediate in the synthesis of more complex molecules, particularly in the development of novel therapeutic agents.

The structural framework of 4-(Chloromethoxy)-3-iodo-5-nitrobenzonitrile consists of a benzene ring substituted with a nitrile group at the 1-position, a nitro group at the 5-position, an iodo atom at the 3-position, and a chloromethoxy group at the 4-position. This arrangement imparts distinct electronic and steric properties to the molecule, making it a versatile building block for further chemical modifications. The presence of both electron-withdrawing (nitro and nitrile groups) and electron-donating (chloromethoxy group) functionalities allows for diverse synthetic pathways, enabling chemists to tailor the compound for specific applications.

In recent years, there has been growing interest in exploring the pharmacological potential of benzonitrile derivatives due to their broad spectrum of biological activities. The nitro group, in particular, is known for its ability to enhance metabolic stability and bioavailability, while the iodo atom can serve as a handle for further functionalization via cross-coupling reactions. These attributes have made 4-(Chloromethoxy)-3-iodo-5-nitrobenzonitrile a attractive candidate for use in drug discovery programs targeting various diseases.

One of the most compelling aspects of this compound is its utility in constructing heterocyclic scaffolds, which are prevalent in many biologically active molecules. The benzonitrile core can be further elaborated into more complex structures by incorporating additional rings or side chains through palladium-catalyzed cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings. The iodo substituent at the 3-position is particularly useful for these transformations, providing a convenient site for introducing new functionalities while maintaining regioselectivity.

Recent studies have highlighted the role of 4-(Chloromethoxy)-3-iodo-5-nitrobenzonitrile in the development of novel anticancer agents. Researchers have demonstrated that benzonitrile derivatives can exhibit potent cytotoxic effects by interfering with key cellular processes such as DNA replication and apoptosis. The nitro group has been shown to enhance the ability of these compounds to generate reactive oxygen species (ROS), which can induce oxidative stress in cancer cells leading to their destruction. Additionally, the chloromethoxy group can be exploited to modulate solubility and bioavailability, improving drug delivery systems.

The iodo atom at the 3-position offers another layer of complexity that can be leveraged in drug design. For instance, it can be used to introduce fluorine or other halogen atoms through metal-catalyzed halogen exchange reactions, which can fine-tune pharmacokinetic properties such as metabolic stability and blood-brain barrier penetration. These modifications are crucial for optimizing drug candidates for clinical use.

In addition to its applications in oncology research, 4-(Chloromethoxy)-3-iodo-5-nitrobenzonitrile has shown promise in other therapeutic areas. Its structural motifs have been explored in the development of antimicrobial agents, where benzonitrile derivatives have demonstrated activity against resistant bacterial strains. The combination of nitro and chloromethoxy groups appears to disrupt bacterial cell wall synthesis or interfere with essential metabolic pathways.

The synthesis of 4-(Chloromethoxy)-3-iodo-5-nitrobenzonitrile involves multi-step organic transformations that require careful optimization to achieve high yields and purity. Typically, it begins with the nitration of a suitable precursor followed by halogenation and methoxylation steps. The introduction of the nitrile group is usually performed via cyanation reactions using reagents such as copper(I) cyanide or potassium cyanide under controlled conditions. Each step must be carefully monitored to prevent unwanted side reactions that could compromise the integrity of the final product.

One challenge in working with this compound is its sensitivity to moisture and air oxidation due to its reactive functional groups. Therefore, storage under inert conditions such as nitrogen or argon is essential to maintain its stability. Additionally, handling should be performed in an environment equipped with appropriate safety measures due to potential irritant properties associated with chlorinated and iodinated compounds.

The growing interest in 4-(Chloromethoxy)-3-iodo-5-nitrobenzonitrile underscores its importance as a key intermediate in modern drug discovery. As synthetic methodologies continue to advance, researchers will likely uncover new ways to exploit its structural features for developing innovative therapeutic strategies. Collaborative efforts between chemists and biologists will be crucial in translating these findings into tangible medical breakthroughs that address unmet clinical needs.

In conclusion,4-(Chloromethoxy)-3-iodo-5-nitrobenzonitrile (CAS No. 1504881-35-9) represents a significant advancement in pharmaceutical chemistry due to its versatile reactivity and broad range of potential applications. Its unique structural features make it an indispensable tool for constructing complex molecules with therapeutic value across multiple disease areas including cancer and infectious diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)